GV20 ONCOTHERAPY

Technology platforms
Novel Immuno-Oncology Targets
Tumor-Specific Fully Human Antibodies
Robust Response Biomarkers

Atlas Genomics PlatformTumor profile,CRISPR screen &
antibody screen
antibody screen
Phial AI PlatformBig data & machine learning algorithms
investors
-
Linear Capital
-
IDG
-
WATSON